Choosing to plant a new apple variety is one of the most significant long-term decisions a grower can make. With orchard investments tied up for decades, the stakes are high, and the wrong choice can have lasting commercial consequences. If you want to explore the apple varieties we have developed and are currently licensing, you are welcome to browse our variety portfolio or simply reach out if you have questions.
This article walks through the key risks involved in planting an unproven apple variety and what growers can do to make more informed, confident decisions before committing land and resources.
What counts as an “unproven” apple variety?
An unproven apple variety is one that lacks sufficient commercial growing data across diverse conditions, seasons, and markets to reliably predict its performance. This typically means the variety has not yet been grown at commercial scale for long enough to demonstrate consistent yield, storability, pest and disease behavior, and consumer acceptance.
It is important to note that “unproven” exists on a spectrum. A variety trialed for two seasons in one region is far less proven than one with five years of data across multiple climates and packing lines. Even varieties that perform brilliantly in breeder trials may behave differently once scaled up across varied soils, microclimates, and orchard management systems. Understanding where a variety sits on that spectrum is the first step in assessing risk.
What are the main risks of planting a new apple variety?
The main risks of planting a new apple variety include unpredictable yield performance, uncertain market demand, limited agronomic knowledge among advisors and growers, and the possibility that the variety does not consistently meet commercial quality standards. Any one of these risks can turn a promising variety into a costly mistake.
Yield consistency is often the first concern. A variety may produce well in its first bearing years but show significant biennial bearing tendencies, where heavy crops alternate with very light ones, making financial planning difficult. Beyond the orchard, there are commercial risks too. If a variety lacks a clear market position or brand identity, growers may struggle to achieve premium pricing, leaving them competing on volume in a crowded category. Supply chain readiness is another factor, as packhouses, retailers, and export partners all need time to adapt to a new variety’s size profile, color requirements, and storage characteristics.
How does disease resistance affect the risk of a new variety?
Disease resistance directly reduces the agronomic and financial risk of growing a new apple variety. A variety with strong tolerance or resistance to common diseases such as scab, powdery mildew, or fire blight requires fewer spray interventions, lowers input costs, and is less vulnerable to crop losses in high-pressure seasons.
At Better3Fruit, disease and pest tolerance is a core breeding goal, not an afterthought. We design new varieties to perform well with reduced chemical inputs, which matters both economically and in terms of meeting increasingly strict retailer and regulatory sustainability requirements. That said, resistance ratings from breeder trials should always be interpreted in the context of local disease pressure. A variety rated as scab-tolerant under Belgian conditions may face different challenges in regions with distinct pathogen populations or wetter climates. Growers should always consult local extension services or advisors to cross-reference resistance data against regional conditions.
Should you plant a club variety or an open variety?
Club varieties offer more commercial structure and market protection, while open varieties provide more planting freedom but less price support. The right choice depends on your scale, your market relationships, and your appetite for commercial risk alongside agronomic risk.
Club varieties are managed under licensing agreements that control supply, enforce quality standards, and support coordinated marketing. This means growers benefit from brand investment and a more predictable price floor, but they also take on obligations around volumes, quality thresholds, and sometimes exclusive sales channels. Open varieties, by contrast, can be planted freely and sold through any channel, but they are exposed to market saturation and price erosion if they become widely planted without brand differentiation. For an unproven variety specifically, the club structure can reduce risk, because the variety manager has a strong incentive to develop the market and support growers through early adoption challenges.
What questions should growers ask before committing to a new variety?
Before planting a new apple variety, growers should ask: How many seasons of commercial trial data exist? In what climates and soil types has it been tested? What is the disease resistance profile? Who manages the marketing, and what is the market development plan? What are the royalty and licensing terms? What support is available if performance falls short of expectations?
Beyond these fundamentals, it is worth asking about the breeding program behind the variety. A variety that comes from a rigorous, science-backed program with multi-stage selection processes is more likely to have had its weaknesses identified and addressed before commercial release. We evaluate over 10,000 new selections per year and maintain more than 30,000 varieties under evaluation at any given time, which means that by the time a variety reaches commercial release, it has undergone extensive scrutiny. Growers should also ask whether independent trial data exist, separate from breeder data, to confirm that performance claims hold up under independent assessment.
How can growers reduce the risk of trialling a new apple variety?
Growers can reduce the risk of trialling a new apple variety by starting with a small, dedicated block rather than committing large areas, partnering with experienced advisors, accessing independent trial data, and choosing varieties backed by a credible breeding program and a clear commercialization strategy.
Start small and structured
A trial planting of even one to two hectares can generate meaningful data about how a variety performs in your specific soil, microclimate, and management system without exposing your whole operation to risk. Keep detailed records from the first season, including flowering timing, fruit set, color development, harvest window, and storage behavior. This data becomes invaluable when making the decision to scale up or walk away.
Lean on the network around the variety
Varieties that come with active grower networks, variety managers, or technical support programs give you access to collective learning. Other growers in the network have likely encountered the same challenges you will face, and that shared knowledge shortens your learning curve significantly. Licensing arrangements that include technical support are worth considering as part of the overall risk calculation, not just the royalty cost.
Taking the time to research, trial carefully, and ask the right questions before committing to new apple varieties is always worth the effort. If you would like to learn more about our varieties or discuss which might suit your operation, get in touch with us directly and we will be happy to help.
Frequently Asked Questions
How long should a new apple variety be trialled before scaling up to full commercial planting?
Most experienced growers and variety managers recommend a minimum of three to five seasons of on-farm trial data before committing to large-scale planting. This timeframe allows you to observe yield consistency across at least one or two biennial bearing cycles, assess storage and packout performance, and gather enough harvest data to make a financially grounded decision. If independent trial data from similar climates is also available, this can help you triangulate your own results and move with greater confidence.
What should I look for when evaluating breeder trial data for a new apple variety?
When reviewing breeder trial data, pay close attention to where and under what conditions the trials were conducted, as results from a single location or climate may not translate to your operation. Look for data on yield consistency across multiple seasons, not just peak performance years, and check whether disease resistance ratings were measured under genuine disease pressure or controlled conditions. Ideally, seek out independent third-party trial reports that corroborate the breeder's own findings, as these provide an unbiased benchmark against which to assess commercial claims.
What are the most common mistakes growers make when adopting a new apple variety?
One of the most frequent mistakes is planting too large an area too soon, before local performance data has been established, which turns a manageable trial into an operation-wide risk. Another common error is underestimating the commercial side of the decision, focusing heavily on agronomic performance while overlooking whether a clear market, brand strategy, and supply chain infrastructure exist to support the variety at scale. Growers also sometimes neglect to keep detailed records during the trial phase, missing the opportunity to build the farm-specific data needed to make a confident scale-up decision.
How do royalty and licensing costs factor into the overall financial risk of a new variety?
Royalty and licensing costs are a real part of the financial equation and should be evaluated alongside projected yield, packout rates, and expected market pricing rather than in isolation. A higher royalty attached to a well-managed club variety with strong market demand and a reliable price floor may represent far less financial risk than a lower-cost open variety exposed to price erosion and market saturation. Always model your expected return per hectare under both optimistic and conservative yield and price scenarios before signing a licensing agreement, and clarify upfront what obligations and support structures come with the arrangement.
Can a new apple variety perform differently on my farm compared to breeder or regional trial results?
Yes, and this is one of the most important realities for growers to keep in mind. Soil type, microclimate, altitude, irrigation management, pruning systems, and even local pollinator populations can all influence how a variety expresses itself in your specific orchard. A variety that consistently delivers high colour in a cool continental climate may struggle to meet colour thresholds in a warmer or more humid region, and disease resistance ratings calibrated to one pathogen population may not hold in areas with different strains. This is precisely why on-farm trialling, even when robust external data exists, remains an essential step before full commitment.
What support should I expect from a breeding company or variety manager after planting?
A reputable breeding company or variety manager should offer more than just the initial licensing agreement. Look for access to technical agronomic guidance, clear protocols for harvest timing and storage management, and ideally a grower network or forum where you can share experiences and troubleshoot challenges with others growing the same variety. Marketing support, including promotional materials, retailer relationships, and a clear brand development roadmap, is equally important and signals that the variety manager is invested in the long-term commercial success of the variety alongside the grower.
Is it worth planting a new apple variety if I don't have an established export market?
It can be, but the risk profile changes significantly depending on whether you are targeting domestic retail, local wholesale, or export channels. Without an established export relationship, it is especially important to confirm that strong domestic demand exists for the variety and that local retailers or packers are willing to support it. For growers without existing export connections, choosing a variety backed by a variety manager with active export market development can provide a route to those markets over time, making the licensing relationship itself a strategic asset rather than just a cost.